Walleye Capital
OM icon

Walleye Capital’s Outset Medical OM Stock Holding History

Walleye Capital’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-56,101
Closed -$1.08M – 4943
2025
Q2 		$1.08M Buy
+56,101
New +$876K ﹤0.01% 1987
2024
Q3 		– Sell
-13,832
Closed -$799K – 5717
2024
Q2 		$799K Buy
13,832
+4,521
+49% +$222K ﹤0.01% 3065
2024
Q1 		$310K Buy
9,311
+8,559
+1,138% +$433K ﹤0.01% 3635
2023
Q4 		$61K Buy
+752
New +$61.2K ﹤0.01% 4240
2022
Q3 		– Sell
-11,880
Closed -$2.65M – 3446
2022
Q2 		$2.65M Buy
11,880
+4,803
+68% +$2.07M 0.07% 287
2022
Q1 		$4.82M Buy
7,077
+2,033
+40% +$1.22M 0.13% 169
2021
Q4 		$3.49M Buy
5,044
+314
+7% +$232K 0.11% 201
2021
Q3 		$3.51K Sell
4,730
-1,027
-18% -$700K 0.1% 137
2021
Q2 		$4.32K Buy
5,757
+4,291
+293% +$3.28M 0.15% 99
2021
Q1 		$1.2K Sell
1,466
-60
-4% -$46.3K 0.07% 246
2020
Q4 		$1.3K Sell
1,526
-727
-32% -$560K 0.09% 204
2020
Q3 		$1.69M Buy
+2,253
New +$1.85M 0.19% 143

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Walleye Capital's OM Position: Q3 2025 in Review

Walleye Capital sold out of Outset Medical (OM) in Q3 2025, closing a stake of 56,101 shares — an estimated $1.08M sold.

Walleye Capital first reported a position in OM in Q3 2020 and held it in 12 quarters. The position peaked at $4.82M in Q1 2022. 101 funds tracked by Wall St. Rank hold OM as of Q3 2025.

  • Walleye Capital reported no remaining Outset Medical position as of Q3 2025 after selling out during the quarter.
  • Walleye Capital sold 56,101 Outset Medical shares in Q3 2025, an estimated $1.08M.
  • Walleye Capital first reported a position in Outset Medical in Q3 2020 and held it in 12 quarters.
  • Walleye Capital's Outset Medical position peaked at $4.82M in Q1 2022.
  • 101 funds tracked by Wall St. Rank held Outset Medical as of Q3 2025.

Based on Walleye Capital's 13F filing for Q3 2025, filed 14 Nov 2025.